消息

NVZMY holds a Zacks Rank of #2 (Buy) versus HWKN’s #3 (Hold), reflecting a sharper earnings‑outlook improvement for the former. Forward‑looking valuation multiples reinforce NVZMY’s relative appeal: its forward P/E sits at 24.53 compared with HWKN’s 31.23, and its PEG ratio is 1.11 against HWKN’s 1.95. The price‑to‑book metric also favours NVZMY, w...

全文

Liberty’s CEO Mike Fries described the collaboration as a “significant milestone” that will generate substantial value for stakeholders. Google Cloud’s EMEA president Tara Brady highlighted the goal of cutting complexity and delivering tangible customer benefits. While financial terms were not disclosed, analysts view the alliance as a transformati...

全文

The alliance also explores running Google Cloud services inside Liberty’s own data centres, addressing European data‑sovernity concerns while potentially increasing capacity for excess customer demand. Liberty will begin offering Google products such as Pixel phones, smart‑watch devices, and YouTube Premium, creating fresh revenue streams and expan...

全文

Liberty Global Ltd. (LBTYA) announced a five‑year strategic partnership with Google Cloud that will embed Google’s Gemini AI models across its European network. The deal focuses on three priorities: AI‑driven customer value, cloud optimisation, and new growth opportunities. Gemini will be integrated into the company’s Horizon TV platform, turning c...

全文

The company’s recent multicenter review reported encouraging 6‑ and 12‑month follow‑up results from a feasibility study using the nPulse Cardiac Catheter. Preclinical work also demonstrated that nanosecond PFA generates substantially deeper tissue lesions than microsecond pulses, underscoring the technology’s therapeutic advantage.

全文

Pulse Biosciences (Nasdaq: PLSE) announced that its nPulse technology will be highlighted at the 31st Annual AF Symposium 2026, where a live case transmission will showcase the nPulse Cardiac Catheter integrated with Abbott’s EnSiteX 3D Mapping System. The live broadcast, scheduled at Na Homolce Hospital in Prague, CZ, will present data on the pote...

全文

Natural Resource Partners L.P. is a high‑quality royalty‑driven company with an expanding renewable‑energy arm. Its robust free cash flow, disciplined capex, and aggressive balance‑sheet improvement strategy position it well for future dividend growth, provided the coal‑industry risks and regulatory environment stay manageable.

全文

- NRP is actively moving toward a “fortress” balance sheet, targeting $30 million of cash and zero permanent debt by the next year. The plan is to leverage this strong liquidity to potentially lift distributions, driven by durable royalty cash flows and a “free‑call” option created by unleased carbon‑sequestration pore space.

全文

The partnership with Tempus is a critical enabler. Tempus provides a one‑click ordering system that accelerates deployment, while PSNL captures a fixed $9.6 M distribution fee plus additional upside through data‑licensing royalties. Projections assume that capturing 6 % of the market by 2029 would generate $100 M EBIT, implying a $2 B valuation at...

全文

Personalis, Inc. (PSNL) stands out as an attractive investment opportunity thanks to its flagship NeXT Personal test, a liquid‑biopsy platform that identifies cancer recurrence 12–18 months earlier than conventional imaging. The assay employs whole‑genome sequencing to track up to 1,800 tumor variants, yielding significantly higher detection rates...

全文